Finally, through our IHC experiments using tissue microarrays containing 17 cases of melanoma and 18 cases of normal skin tissues, we confirmed that GBP5 exhibited significantly higher expression levels in melanoma tumor tissues compared to normal tissues (Figures 10C, D). This evidence concerns the gene GBP5 and neoplasm.